Abstract PS1-11-12: Rac/cdc42 inhibitor MBQ-167 in the estrogen receptor positive breast cancer tumor microenvironment

Authors

Institutions

Publication Details

Journal
Clinical Cancer Research
Published
2026-02-17
DOI
https://doi.org/10.1158/1557-3265.sabcs25-ps1-11-12
Primary Topic
Advanced Breast Cancer Therapies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract PS1-11-12: Rac/cdc42 inhibitor MBQ-167 in the estrogen receptor positive breast cancer tumor microenvironment

Anamaris Torres-Sanchez, Nilmary Grafals, Verónica Negrón, Riccardo Papa et al.
Clinical Cancer Research
Advanced Breast Cancer Therapies
article

Abstract PS1-11-12: Rac/cdc42 inhibitor MBQ-167 in the estrogen receptor positive breast cancer tumor microenvironment

Anamaris Torres-Sanchez, Nilmary Grafals, Verónica Negrón, Riccardo Papa, Stephanie Dorta‐Estremera, Victor P. Carlo, H. Fogle, A. Cruz Collazo, S. Dharmawardhane, N. Zaragoza-Rodriguez, H. Franco
article en

Abstract

No abstract available for this paper.
Clinical Cancer ResearchVol. 32(4_Supplement)
University of Puerto Rico, Medical Sciences Campus (PR), University of Puerto Rico at Río Piedras (PR), Translational Research in Oncology (FR), Auxilio Mutuo Hospital (PR)
Good health and well-being
Openalex Percentile: Top 52%
Advanced Breast Cancer Therapies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.